Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Timed smartphone support to boost social connections for people waiting for outpatient psychotherapy

Official title: Activating Social Resources in Psychotherapy-Seeking Individuals: Effectiveness and Timing of a Social Support Just-in-Time Adaptive Intervention

Run by University of Zurich · NCT07471529 · Data updated 2026-11-12

This project tests whether a smartphone-based just-in-time support program can reduce daily depressive symptoms and increase received social support for adults waiting for outpatient psychotherapy.

More Loneliness trials

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment120 (estimated)
SponsorUniversity of Zurich
Academic / other
Locations1 site (Zurich, Canton of Zurich)
StatusRecruiting
StartedApril 22, 2026
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedApril 30, 2026
Trial IDNCT07471529 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–70 who are seeking outpatient psychotherapy, report elevated depressive symptoms (BDI-II > 13), own a smartphone, and can provide informed consent are ideal candidates, provided they are not scheduled to start therapy within four weeks and do not meet exclusion criteria.

Probably not a fit

People with imminent psychotherapy starts (within four weeks), significant suicidal ideation, manic symptoms, shift workers, or those without a smartphone are unlikely to benefit from this JITAI.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This 21-day micro-randomized trial uses a just-in-time adaptive intervention (JITAI) delivered via smartphone with six brief assessments per day. Each day participants are randomized across four conditions: vulnerability-triggered, vulnerability-and-receptivity-triggered, support-need-triggered, or no-intervention control. Primary outcomes are daily depressive symptoms and received social support, with secondary outcomes of daily loneliness and perceived social support. The trial compares the relative effectiveness of three different triggering strategies to identify the best timing for delivering support prompts.

Why it matters

Potential benefit: If successful, the intervention could offer a low-burden smartphone tool to reduce day-to-day depressive symptoms and strengthen social support for people waiting for therapy.

How similar studies have gone: Previous JITAI and ecological momentary intervention studies in mental health have shown promise for reducing symptoms and improving support, but direct comparisons of multiple triggering strategies in this population are novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* indicating to seek outpatient psychotherapy
* elevated levels of self-reported depressive symptoms (Beck Depression Inventory-II (BDI) score \> 13 (out of 63); Kühner et al., 2007)
* owning a smartphone
* signing the informed consent form

Exclusion Criteria:

* first session for outpatient psychotherapy is scheduled within four weeks
* suicidal ideation (values \> 2 in BDI item 9)
* presence of manic symptoms (Mood Disorder Questionnaire (MDQ) score \> 7), - shift work
* age below 18 or above 70

Where it's running

  • University of Zurich
    Zurich, Canton of Zurich, Switzerland
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.